Form 4: Exact Sciences EVP Sarah Condella Sells 2,000 Shares Under 10b5-1 Plan
SEC Form 4 Filing
Sarah Condella, EVP of Human Resources at Exact Sciences, sold 2,000 shares of common stock at $70 per share on March 28, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On March 28, 2024, Sarah Condella, the EVP of Human Resources at Exact Sciences Corp, sold 2,000 shares of the company's common stock.
- The sale was executed at a price of $70 per share.
- This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan established on May 18, 2023.
- Following the transaction, Ms. Condella directly owns 73,787 shares of Exact Sciences common stock.
- Additionally, she indirectly owns 5,726 shares through a 401(k) plan.
- Ms. Condella also holds 89,250 vested and unvested options and restricted stock units (RSUs), each RSU representing the right to receive one share of common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine stock sale under a pre-existing trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company executives, which is important for investors to monitor.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a relatively small sale by an executive under a pre-arranged trading plan.
Key Dates
| Date | Description |
|---|---|
| 05/18/2023 | Date of entry into Rule 10b5-1 trading plan |
| 03/28/2024 | Date of stock sale transaction |
| 04/01/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.